Mogroside V

Catalog No.S3815 Batch:S381501

Print

Technical Data

Formula

C60H102O29

Molecular Weight 1287.43 CAS No. 88901-36-4
Solubility (25°C)* In vitro DMSO 100 mg/mL (77.67 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Mogroside V is a natural cucurbitane glycoside which has a sweetening strength of 250 times that of sucrose and is derived from mature fruit of luo-han-guo (Siraitia grosvenorii, monk fruit).
In vitro Mogroside V possesses tumor growth inhibitory activity in in vitro and in vivo models of pancreatic cancer by promoting apoptosis and cell cycle arrest of pancreatic cancer cells (PANC-1 cells), which may in part be mediated through regulating the STAT3 signaling pathway. Mogroside V inhibits the proliferation of pancreatic cancer cells and other tumor cell types in a dose- and time-dependent manner, and shows very little cytotoxicity against the non-tumorigenic epithelial cell line L02. Mogroside V inhibits the downstream targets of the STAT3 pathway that promote cell proliferation (CCND1, CCNE1 and CDK2), while also upregulating cell cycle inhibitors (CDKN1A and CDKN1B)[1].
In vivo Mogroside V treatment promotes apoptosis of pancreatic cancer cells in the xenograft tumors. Mogroside V treatment significantly reduces the expression of CD31-labeled blood vessels and of the pro-angiogenic factor vascular endothelial growth factor in the xenografts, indicating that mogroside V might limit the growth of pancreatic tumors by inhibiting angiogenesis and reducing vascular density. Mogroside V treatment inhibits tumor cell growth, induces apoptosis and causes tumor regression[1].

Protocol (from reference)

Cell Assay:[1]
  • Cell lines

    PANC-1 cells

  • Concentrations

    0 to 250 μmol/l

  • Incubation Time

    24 or 72 h

  • Method

    Cells are added to 96-well cell culture plates at an initial concentration of 1 × 104 cells/ml and are incubated with the indicated concentrations of mogroside V. After 24 or 72 h of incubation, MTT solution (5 mg/ml) is added to the wells and the cells are incubated for another 4 h. The growth medium is removed and formazan crystals formed by oxidation of the MTT dye are analyzed by measuring the absorbance at 490 nm using an ELISA reader.

Animal Study:[2]
  • Animal Models

    BALB/c nude mice xenografted with PANC-1 cells

  • Dosages

    2 mg/kg, 10 mg/kg, 30 mg/kg

  • Administration

    i.v.

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.